Click to search

Comments on "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder".

Authors

Journal

J Clin Psychopharmacol. 2009 Aug;29(4):411-2; author reply 412. doi: 10.1097/JCP.0b013e3181ace848.

Affiliation

Comment on

PMID

19593196 [PubMed - indexed for MEDLINE]
Lippincott Williams & Wilkins: Full text
 Citation 2 of 2806 Back to results 
Standard PubMed